Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BURNING ROCK BIOTECH LIMITED

(BNR)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/22/2021 09/23/2021 09/24/2021 09/27/2021 09/28/2021 Date
20.37(c) 20.6(c) 18.74(c) 18.38(c) 17.37 Last
66 322 194 058 445 349 420 727 396 467 Volume
+0.69% +1.13% -9.03% -1.92% -5.50% Change
More quotes
Estimated financial data (e)
Sales 2021 503 M 78,0 M 78,0 M
Net income 2021 -395 M -61,2 M -61,2 M
Net cash position 2021 1 443 M 224 M 224 M
P/E ratio 2021 -31,3x
Yield 2021 -
Sales 2022 717 M 111 M 111 M
Net income 2022 -215 M -33,3 M -33,3 M
Net cash position 2022 978 M 152 M 152 M
P/E ratio 2022 -57,5x
Yield 2022 -
Capitalization 12 406 M 1 922 M 1 923 M
EV / Sales 2021 21,8x
EV / Sales 2022 15,9x
Nbr of Employees 938
Free-Float 72,4%
More Financials
Company
Burning Rock Biotech Ltd is a holding company mainly engaged in the next generation sequencing (NGS) based cancer therapy selection. The Company operates three segments. Central Laboratory Business segment is engaged in the sales of cancer therapy selection test to individual patients. In-Hospital Business segment is engaged in the sales of reagent kits and the provision of the facilitation services for the sale of... 
More about the company
Ratings of Burning Rock Biotech Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about BURNING ROCK BIOTECH LIMITED
09/14BURNING ROCK BIOTECH : and CStone Pharmaceuticals reached a strategic collaboration on the..
PU
09/14BURNING ROCK BIOTECH : deepens cooperation with Illumina to promote development and standa..
PU
09/14BURNING ROCK BIOTECH : initiates the first prospective, multi-center pan-cancer early dete..
PU
09/14BURNING ROCK BIOTECH : Dx Launches Magnis BR to Innovate Total Process Automation for NGS ..
PU
09/14BURNING ROCK BIOTECH : announces the completion of the Series C financing of RMB 850 milli..
PU
09/14BURNING ROCK BIOTECH : China's first NGS cancer testing kit made by Burning Rock Dx and li..
PU
09/14BURNING ROCK BIOTECH : Dx Honored with 2018 Guangzhou Hi-tech “Unicorn” and &l..
PU
09/14BURNING ROCK BIOTECH : Dx Certified by the Certification of ISO 13485 Quality Management S..
PU
09/14BURNING ROCK BIOTECH : and Illumina Collaborate on Molecular Diagnostics for Oncology
PU
08/31SECTOR UPDATE : Health Care Stocks Mixed Pre-Bell Tuesday
MT
08/31BURNING ROCK BIOTECH : Reports Second Quarter 2021 Financial Results (Form 6-K)
PU
08/31BURNING ROCK BIOTECH : Q2 Net Loss Narrows, Revenue Rises
MT
08/31BURNING ROCK BIOTECH : Q2 2021 Presentation Slides
PU
08/31Burning Rock Reports Second Quarter 2021 Financial Results
GL
08/31Burning Rock Biotech Limited Reports Unaudited Earnings Results for the Second Quarter ..
CI
More news
News in other languages on BURNING ROCK BIOTECH LIMITED
08/31Burning Rock réduit sa perte nette au deuxième trimestre et augmente ses recettes
More news
Analyst Recommendations on BURNING ROCK BIOTECH LIMITED
More recommendations
Chart BURNING ROCK BIOTECH LIMITED
Duration : Period :
Burning Rock Biotech Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BURNING ROCK BIOTECH LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 118,66 CNY
Average target price 211,13 CNY
Spread / Average Target 77,9%
EPS Revisions
Managers and Directors
Yu Sheng Han Chairman & Chief Executive Officer
Leo Li Chief Financial Officer & Director
Zhi Hong Zhang Chief Technology Officer
Shao Kun Chuai Chief Operating Officer & Director
Wendy Hayes Independent Director
Sector and Competitors